AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 200 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $586,231 | -18.9% | 75,448 | +1.0% | 0.00% | – |
| Q2 2023 | $722,777 | -35.5% | 74,667 | -27.0% | 0.00% | -100.0% |
| Q1 2023 | $1,120,835 | +221.8% | 102,266 | +26.8% | 0.00% | – |
| Q4 2022 | $348,352 | -23.6% | 80,637 | +33.0% | 0.00% | – |
| Q3 2022 | $456,000 | -42.0% | 60,639 | -22.4% | 0.00% | – |
| Q2 2022 | $786,000 | +627.8% | 78,178 | +793.8% | 0.00% | – |
| Q1 2022 | $108,000 | -42.2% | 8,747 | +6.9% | 0.00% | – |
| Q4 2021 | $187,000 | +14.0% | 8,185 | +10.4% | 0.00% | – |
| Q3 2021 | $164,000 | -92.2% | 7,417 | -95.4% | 0.00% | -100.0% |
| Q2 2021 | $2,108,000 | +1058.2% | 162,679 | +1059.3% | 0.00% | – |
| Q1 2021 | $182,000 | +122.0% | 14,033 | +135.3% | 0.00% | – |
| Q4 2020 | $82,000 | -57.3% | 5,963 | -54.2% | 0.00% | – |
| Q3 2020 | $192,000 | +125.9% | 13,011 | +149.8% | 0.00% | – |
| Q2 2020 | $85,000 | -4.5% | 5,208 | -14.7% | 0.00% | – |
| Q1 2020 | $89,000 | -77.9% | 6,108 | -69.2% | 0.00% | – |
| Q4 2019 | $402,000 | +3920.0% | 19,857 | +1125.0% | 0.00% | – |
| Q2 2019 | $10,000 | -99.1% | 1,621 | -99.0% | 0.00% | -100.0% |
| Q1 2019 | $1,107,000 | +145.5% | 170,455 | +157.5% | 0.00% | – |
| Q4 2018 | $451,000 | +79.0% | 66,200 | +74.1% | 0.00% | – |
| Q3 2018 | $252,000 | +3.3% | 38,017 | -12.4% | 0.00% | – |
| Q2 2018 | $244,000 | +24.5% | 43,408 | +14.6% | 0.00% | – |
| Q1 2018 | $196,000 | +366.7% | 37,879 | +299.7% | 0.00% | – |
| Q4 2017 | $42,000 | -87.5% | 9,478 | -82.3% | 0.00% | – |
| Q3 2017 | $335,000 | +8.4% | 53,652 | +6.2% | 0.00% | – |
| Q2 2017 | $309,000 | +10.0% | 50,500 | +31.5% | 0.00% | – |
| Q1 2017 | $281,000 | +28000.0% | 38,400 | +6300.0% | 0.00% | – |
| Q4 2016 | $1,000 | -99.8% | 600 | -99.5% | 0.00% | – |
| Q1 2015 | $581,000 | +19.8% | 133,333 | 0.0% | 0.00% | – |
| Q4 2014 | $485,000 | +13.8% | 133,333 | 0.0% | 0.00% | – |
| Q3 2014 | $426,000 | – | 133,333 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Berry Street Capital Management LLP | 1,987,500 | $24,605,000 | 2.79% |
| NEA Management Company, LLC | 3,969,834 | $49,146,000 | 1.42% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 133,117 | $1,648,000 | 0.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 435,000 | $3,955,000 | 0.89% |
| ACT CAPITAL MANAGEMENT, LLC | 67,500 | $836,000 | 0.88% |
| Artal Group S.A. | 1,000,000 | $12,380,000 | 0.52% |
| CTC Capital Management, LLC | 12,800 | $158,000 | 0.42% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 581,910 | $7,204,000 | 0.36% |
| Affinity Asset Advisors, LLC | 175,000 | $2,167,000 | 0.35% |
| Bellevue Group AG | 2,405,825 | $29,784,000 | 0.35% |